Prestige Consumer Healthcare Inc. $PBH Shares Sold by Vanguard Group Inc.

Key Points

• Vanguard Group Inc. sold 54,861 shares of Prestige Consumer Healthcare, reducing its stake by 1.0%, and now owns approximately 5.6 million shares valued at $484.5 million.
• Prestige Consumer Healthcare reported a quarterly earnings of $0.95 per share, missing expectations, with a revenue of $249.53 million, down 6.6% from the previous year.
• Analyst consensus ratings for Prestige Consumer Healthcare indicate a "Hold" with an average target price of $93.33, following changes from several institutions regarding their ratings.

Vanguard Group Inc. trimmed its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 1.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,635,298 shares of the company's stock after selling 54,861 shares during the quarter. Vanguard Group Inc. owned approximately 11.38% of Prestige Consumer Healthcare worth $484,467,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of PBH. Westwood Holdings Group Inc. lifted its position in Prestige Consumer Healthcare by 7.1% in the first quarter. Westwood Holdings Group Inc. now owns 861,282 shares of the company's stock worth $74,044,000 after buying an additional 56,802 shares during the last quarter. Costello Asset Management INC purchased a new stake in shares of Prestige Consumer Healthcare in the 1st quarter worth $112,000. Blair William & Co. IL lifted its stake in Prestige Consumer Healthcare by 16.4% in the first quarter. Blair William & Co. IL now owns 106,114 shares of the company's stock worth $9,123,000 after acquiring an additional 14,967 shares during the period. Jefferies Financial Group Inc. bought a new position in Prestige Consumer Healthcare during the 1st quarter worth about $203,000. Finally, Pacific Capital Partners Ltd purchased a new position in Prestige Consumer Healthcare during the 1st quarter valued at about $1,075,000. Institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Up 0.7%

Shares of NYSE:PBH traded up $0.44 during mid-day trading on Tuesday, reaching $65.31. 45,760 shares of the company were exchanged, compared to its average volume of 386,151. Prestige Consumer Healthcare Inc. has a 1 year low of $62.95 and a 1 year high of $90.04. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99. The firm's 50-day simple moving average is $76.85 and its 200 day simple moving average is $81.54. The firm has a market cap of $3.21 billion, a price-to-earnings ratio of 15.34, a P/E/G ratio of 2.05 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing the consensus estimate of $1.01 by ($0.06). The firm had revenue of $249.53 million for the quarter, compared to analysts' expectations of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%. The company's quarterly revenue was down 6.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.90 earnings per share. Equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on PBH. Wall Street Zen downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Finally, Canaccord Genuity Group lowered their price target on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $93.33.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.